/PRNewswire/ XNK Therapeutics AB ("XNK") today announced that Johan Liwing, CEO, will present the company at the Redeye Regenerative Medicine/Cell Therapy.
/PRNewswire/ XNK Therapeutics AB today announced that Anna-Karin Maltais, Chief Scientific Officer, will be speaking at the 2nd Annual Innate Killer Europe.
/PRNewswire/ The annual CAR-TCR Summit is the world s pre-eminent industry-leading comprehensive forum that unites the global cell therapy community across.
/PRNewswire/ XNK Therapeutics AB ("XNK") today announced that the company has entered into a research collaboration with the Karolinska University Hospital,.
/PRNewswire/ XNK Therapeutics AB ("XNK") today announced that the company has entered into an agreement with a US biotechnology company. Under the agreement.